Researchers have developed a fast and inexpensive way to make facial prostheses for eye cancer patients using facial scanning software and 3-D printing, according to findings released at AAO 2014…
Clinical trials accumulate data for novel anti-VEGF
CHICAGO — A new anti-VEGF indicated for use in wet age-related macular degeneration achieved clinically meaningful and durable vision improvement in several studies with reduced dosing, according to a speaker here.Conbercept, a fusion protein produced in a manner similar to Elyea (aflibercept, Regeneron) is approved for use in China, and discussions are underway to bring this drug to the U.S. and other countries, Peter K. Kaiser, MD, told colleagues at the Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting.
In vivo confocal microscopy useful in noninvasive diagnosis of eyelid margin lesions
In vivo confocal microscopy can aid in the noninvasive diagnosis of eyelid margin tumors when used with a handheld, dermatology-specific microscope, researchers reported.Researchers prospectively analyzed the in vivo reflectance confocal microscopy (IV…
DALK improves vision in eyes with <i>Acanthamoeba</i> keratitis scarring
CHICAGO – Deep anterior lamellar keratoplasty showed promise in restoring vision in eyes with significant corneal scarring from Acanthamoeba keratitis, a speaker said here.DALK should be considered early as a treatment option in cases with active, resistant infection that are unresponsive to medical treatment, Caterina Sarnicola, MD, said at the American Academy of Ophthalmology meeting.
New Standardized DMEK Technique Saves Eyes
The Descemet membrane endothelial keratoplasty (DMEK) approach eliminates upside-down grafts and has a low rate of graft failure. Medscape Medical News
DMEK yields fast visual recovery for endothelial dysfunction
CHICAGO — Six-year midterm results showed Descemet’s membrane endothelial keratoplasty for the treatment of endothelial dysfunction provides fast and potentially complete visual recovery, a speaker said here.“With our cohort, visual acuity improvements were quite impressive, and by 6 months, more than 95% of patients achieved 20/40 vision,” Fook Chang Lam, MBChB, MRCP, FRCOphth, said at the American Academy of Ophthalmology meeting.